Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

被引:740
作者
Stummer, W [1 ]
Novotny, A [1 ]
Stepp, H [1 ]
Goetz, C [1 ]
Bise, K [1 ]
Reulen, HJ [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Neurosurg, Laser Res Lab,Inst Neuropathol, D-81366 Munich, Germany
关键词
glioma; porphyrin; 5-aminolevulinic acid; fluorescence-guided resection;
D O I
10.3171/jns.2000.93.6.1003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. It has been established that 5-aminolevulinic acid (5-ALA) induces the accumulation of fluorescent porphyrins in glioblastoma multiforme (GBM), a phenomenon potentially exploitable to guide tumor resection. In this study the authors analyze the influence of fluorescence-guided resection on postoperative magnetic resonance (MR) imaging and survival in a series of patients who underwent surgery in the authors' department. Methods. Fifty-two consecutive patients with GEM received oral doses of 5-ALA (20 mg/kg body weight) 3 hours before induction of anesthesia. Intraoperatively, tumor fluorescence was visualized using a modified operating microscope. Fluorescing tissue was removed whenever it was considered safely possible. Residual enhancement on early postoperative MR imaging was quantified and related to each patient's characteristics to determine which factors influenced resection. Survival was analyzed using the Kaplan-Meier method and multivariate analysis was performed in which the Karnofsky Performance Scale (KPS) score, residual fluorescence, patient age, and residual enhancement on MR images were considered. Intraoperatively, two fluorescence qualities were perceived: solid fluorescence generally reflected coalescent tumor, whereas vague fluorescence mostly corresponded to infiltrative tumor. Complete resection of contrast-enhancing tumor was accomplished in 33 patients (63%). Residual intraoperative tissue fluorescence left unresected for safety reasons predicted residual enhancement on MR images in 18 of the 19 remaining patients. Age, residual solid fluorescence, and absence of contrast enhancement in MR imaging were independent explanatory factors for survival, whereas the KPS score was significant only in univariate analysis. No perioperative deaths and one case of permanent morbidity were encountered. Conclusions. The observations in this study indicate the usefulness of 5-ALA-induced tumor fluorescence for guiding tumor resection. The completeness of resection, as determined intraoperatively from residual tissue fluorescence, was related to postoperative MR imaging findings and to survival in patients suffering from GEM.
引用
收藏
页码:1003 / 1013
页数:11
相关论文
共 42 条
[21]   THE CLINICAL USE OF FLUORESCEIN IN NEUROSURGERY - THE LOCALIZATION OF BRAIN TUMORS [J].
MOORE, GE ;
PEYTON, WT ;
FRENCH, LA ;
WALKER, WW .
JOURNAL OF NEUROSURGERY, 1948, 5 (04) :392-398
[22]   IMPROVED SURGICAL RESECTION OF HUMAN-BRAIN TUMORS .1. A PRELIMINARY-STUDY [J].
MURRAY, KJ .
SURGICAL NEUROLOGY, 1982, 17 (05) :316-319
[23]   THE ROLE OF SURGERY IN THE MANAGEMENT OF SUPRATENTORIAL INTERMEDIATE AND HIGH-GRADE ASTROCYTOMAS IN ADULTS .36. [J].
NAZZARO, JM ;
NEUWELT, EA .
JOURNAL OF NEUROSURGERY, 1990, 73 (03) :331-344
[24]  
NITTA T, 1995, CANCER-AM CANCER SOC, V75, P2727, DOI 10.1002/1097-0142(19950601)75:11<2727::AID-CNCR2820751115>3.0.CO
[25]  
2-H
[26]   LASER-INDUCED FLUORESCENCE - EXPERIMENTAL INTRAOPERATIVE DELINEATION OF TUMOR RESECTION MARGINS [J].
POON, WS ;
SCHOMACKER, KT ;
DEUTSCH, TF ;
MARTUZA, RL .
JOURNAL OF NEUROSURGERY, 1992, 76 (04) :679-686
[27]   THE RELATIONSHIP BETWEEN SURVIVAL AND THE EXTENT OF THE RESECTION IN PATIENTS WITH SUPRATENTORIAL MALIGNANT GLIOMAS [J].
QUIGLEY, MR ;
MAROON, JC .
NEUROSURGERY, 1991, 29 (03) :385-389
[28]   PHOTOSENSITIZATION AND PHOTODYNAMIC THERAPY OF ESOPHAGEAL, DUODENAL, AND COLORECTAL RUMORS USING 5-AMINOLEVULINIC ACID-INDUCED PROTOPORPHYRIN-IX - A PILOT-STUDY [J].
REGULA, J ;
MACROBERT, AJ ;
GORCHEIN, A ;
BUONACCORSI, GA ;
THORPE, SM ;
SPENCER, GM ;
HATFIELD, ARW ;
BOWN, SG .
GUT, 1995, 36 (01) :67-75
[29]   MULTIMODALITY MANAGEMENT OF RECURRENT ADULT MALIGNANT GLIOMAS - RESULTS OF A PHASE-II MULTIAGENT CHEMOTHERAPY STUDY AND ANALYSIS OF CYTOREDUCTIVE SURGERY [J].
ROSTOMILY, RC ;
SPENCE, AM ;
DUONG, D ;
MCCORMICK, K ;
BLAND, M ;
BERGER, MS .
NEUROSURGERY, 1994, 35 (03) :378-388
[30]   Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome [J].
Shrieve, DC ;
Alexander, E ;
Black, PM ;
Wen, PY ;
Fine, HA ;
Kooy, HM ;
Loeffler, JS .
JOURNAL OF NEUROSURGERY, 1999, 90 (01) :72-77